Skip to main content

Digestive health

Barrett's oesophagus: symptoms, diet, treatment and cancer risk

Barrett's oesophagus is a change in the cells lining the lower gullet, usually caused by long-term acid reflux. It often causes heartburn but can have no symptoms. Most people never develop cancer, although the risk is higher than in the general population. It is diagnosed by endoscopy and biopsy, managed with acid-reducing medicine and lifestyle changes, and monitored by regular endoscopy.

Last checked: 2026-10-11

Key facts

At a glance.

  • What it is

    Guts UK says that in Barrett's oesophagus normal cells of the gullet change into cells that do not look normal, starting where the oesophagus and stomach meet and spreading upwards.

  • Main cause

    The exact cause is unknown but it is strongly linked to long-term gastro-oesophageal reflux disease (GORD): about 11 in 100 people with GORD will get Barrett's oesophagus, says Guts UK.

  • Cancer risk

    Guts UK says people with Barrett's are 30 times more likely than the general population to develop oesophageal adenocarcinoma, but only 1 in 300 will develop this cancer each year.

  • Symptoms

    The main symptom is reflux: heartburn and regurgitation. Guts UK says some people have no symptoms because the oesophagus is less sensitive to reflux.

  • Diagnosis

    By endoscopy, with biopsies taken to confirm the diagnosis and look for abnormal cells (dysplasia).

  • Monitoring

    Guts UK says guidelines suggest surveillance endoscopy every 2 to 3 years for long-segment Barrett's (3cm or more) and every 3 to 5 years for short-segment with intestinal metaplasia.

What is Barrett's oesophagus?

Guts UK explains that in Barrett's oesophagus the normal cells lining the gullet change and become cells that do not look normal. The change over time makes the lining resemble the lining of the bowel, which is called intestinal metaplasia. It is possible for Barrett's to lead to cancer, but Guts UK says this happens in a few people and most will not develop cancer.

Doctors can grade abnormal cells (dysplasia) as low or high grade. Guts UK says dysplasia increases the risk of cancer in Barrett's oesophagus.

What are the symptoms of Barrett's oesophagus?

Guts UK says the main symptom is reflux: heartburn (a burning feeling behind the breastbone) and bringing food back up (regurgitation), sometimes with a metallic taste or a sore throat. Symptoms are worse after lying down, and waking from reflux symptoms at night is a strong risk factor. Sometimes people do not report symptoms because the oesophagus is less sensitive to reflux, and ignoring symptoms or self-medicating with antacids can delay diagnosis.

Guts UK lists warning symptoms that should prompt you to see a doctor: trouble swallowing, frequent regurgitation or being sick after eating or drinking, pain on swallowing, weight loss, anaemia (tiredness), vomiting blood and a hoarse voice. The NHS says to see a GP if you have heartburn most days, food getting stuck in your throat, frequently being sick or losing weight for no reason.

What should I eat and avoid with Barrett's oesophagus?

Guts UK lists lifestyle changes aimed at reducing acid reflux: weight loss, drinking less alcohol, stopping smoking, smaller meal portions and not eating within three hours of bedtime. The NHS heartburn advice adds eating smaller, more frequent meals, avoiding food and drink that trigger your symptoms (coffee, tomatoes, alcohol, chocolate, fatty or spicy foods are commonly mentioned), not wearing tight clothes around the waist, and raising the head of your bed by around 10 to 20cm rather than adding pillows.

The NHS says these measures help symptoms. Guts UK says that lifestyle changes and medicines do not remove Barrett's oesophagus, so they do not eliminate the small risk of cancer, and that you should continue to take medical treatment if you have been diagnosed.

How is Barrett's oesophagus diagnosed?

Guts UK says doctors diagnose it by looking at the lining of the oesophagus with an endoscopy, a small tube with a camera on the end passed through the mouth, sometimes with throat spray or sedation. Barrett's is identified by its red lining, which replaces the normal pink lining, and biopsies are taken to confirm the diagnosis and check for dysplasia.

A transnasal endoscope, which is thinner and passed through the nose, is available in some centres. The capsule sponge test, which involves swallowing a capsule on a thread that collects cells from the lining, is available in some areas of the UK for people with persistent heartburn and reflux; if it shows cell changes, you will be asked to attend for an endoscopy.

The endoscopist describes the length using the Prague classification: C is the circumferential length and M the maximum length. Guts UK gives M5C4 as an example of a segment 5cm long at its longest point and 4cm fully around the gullet.

How is Barrett's oesophagus treated?

Guts UK says people without dysplasia are at low risk of cancer and are managed with medicines (mostly proton pump inhibitors such as omeprazole or lansoprazole, which reduce stomach acid), lifestyle changes and, if these do not help, sometimes keyhole anti-reflux surgery (laparoscopic Nissen fundoplication).

For dysplasia, treatment has changed in recent years. Guts UK says endoscopic therapy at specialist centres removes or treats the affected lining without major surgery, replacing oesophagectomy for most people with high-grade dysplasia or early cancer.

Endoscopic treatments described by Guts UK
TreatmentWhat it doesNotes
Endoscopic mucosal resection (EMR)Removes small areas of abnormal lining; also gives more information than a biopsyBleeding in about 1 in 50, perforation in about 1 in 200; narrowing of the scar in about 1 in 20
Endoscopic submucosal dissection (ESD)Removes early-stage cancer in the lining, often larger areasDone under general anaesthetic; perforation risk about 1 in 50
Radiofrequency ablation (RFA)Burns away abnormal cells on flat areas of liningThe preferred first-line technique in the UK for high-grade dysplasia; several treatments may be needed
CryotherapyFreezes abnormal cellsIn the UK, used as part of research studies

How often is Barrett's oesophagus monitored?

Guts UK says people are usually entered into a surveillance programme with regular endoscopy and biopsies, and that capsule sponge may be offered instead in some hospitals. Guidelines suggest endoscopy every 2 to 3 years for long-segment Barrett's (3cm or more) and every 3 to 5 years for short-segment (under 3cm) with intestinal metaplasia. If low-grade dysplasia is found, a repeat endoscopy in 6 months is ordered, and people with high-grade dysplasia are quickly referred to a specialist centre.

It adds that a biopsy finding no dysplasia at one endoscopy does not mean someone will never get dysplasia or cancer, and that people with short-segment Barrett's without intestinal metaplasia would not usually be offered surveillance because they are not at increased cancer risk.

Does Barrett's oesophagus lead to cancer?

Guts UK says people with Barrett's oesophagus are 30 times more likely than the general population to develop oesophageal adenocarcinoma, but only 1 in every 300 patients with Barrett's will develop this cancer each year, which it describes as uncommon and a small risk. If cancer is found, it may be treated endoscopically, with surgery or with chemotherapy depending on stage.

Guts UK also notes that persistent reflux can sometimes cause a stricture, a narrowing of the gullet that can make swallowing hard and can be treated by stretching at endoscopy.

What causes Barrett's oesophagus?

Guts UK says the exact cause is unknown but it is strongly linked to long-term GORD, with about 11 in 100 people with GORD getting Barrett's and the risk rising with the length of time and frequency of symptoms. Other risk factors include older age, being male (more common in white men), a family history, a higher than healthy body weight, smoking and a hiatus hernia.

NHS and private pathways

On the NHS, a GP can refer you for endoscopy, and surveillance and endoscopic treatment are organised through hospital gastroenterology services and specialist centres. Guts UK suggests asking your doctor whether other medicines could be tried, how often you need an endoscopy, and whether there is a specialist nurse or support group in your area. Some people choose private endoscopy for speed; ask how results and surveillance plans will be shared with your GP.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • What is Barrett's oesophagus?

    A change in the cells lining the lower gullet, where normal cells are replaced by cells that look like the bowel lining. Guts UK says it is strongly linked to long-term acid reflux and that it can, in a few people, lead to cancer, although most will not develop it.

  • What are the symptoms of Barrett's oesophagus?

    Reflux symptoms such as heartburn and regurgitation, sometimes with a metallic taste or sore throat, worse after lying down. Some people have no symptoms because the oesophagus is less sensitive. Trouble swallowing, weight loss and vomiting blood are warning signs to see a doctor.

  • Will Barrett's oesophagus turn into cancer?

    Probably not. Guts UK says people with Barrett's are 30 times more likely than the general population to develop oesophageal adenocarcinoma, but only 1 in 300 people with Barrett's will develop it each year, and it describes this as a small risk.

  • How is Barrett's oesophagus diagnosed?

    With an endoscopy, in which a camera on a thin tube looks at the gullet lining and biopsies are taken for the laboratory. A capsule sponge test is available in some areas for people with persistent reflux, and an abnormal result leads to an endoscopy.

  • What diet is best for Barrett's oesophagus?

    There is no special diet, but Guts UK suggests smaller portions, not eating within three hours of bedtime, losing weight, less alcohol and stopping smoking. The NHS adds avoiding foods and drinks that trigger your symptoms and raising the head of the bed 10 to 20cm.

  • Can Barrett's oesophagus be cured?

    Medicines and lifestyle changes control reflux but do not remove Barrett's. Guts UK says endoscopic treatments such as radiofrequency ablation can remove abnormal cells in people with dysplasia, but they are usually used when dysplasia is found rather than for everyone.

  • How often do I need an endoscopy?

    It depends on the length and type of Barrett's. Guts UK says guidelines suggest every 2 to 3 years for long segments (3cm or more) and every 3 to 5 years for short segments with intestinal metaplasia. Your own interval may be adjusted for age, sex and family history.

  • What treatments are there for dysplasia?

    Endoscopic mucosal resection, endoscopic submucosal dissection and radiofrequency ablation, usually at specialist centres. Guts UK says radiofrequency ablation is the preferred first-line technique in the UK for high-grade dysplasia, and low-grade dysplasia is usually re-checked after six months.

  • Do I need to take acid-reducing medicine for life?

    Guts UK says you should continue to take medical treatment if you have been diagnosed with Barrett's oesophagus. The most used medicines are proton pump inhibitors such as omeprazole and lansoprazole. Discuss any change with your doctor rather than stopping medication yourself.

  • What is the capsule sponge test?

    A swallowed capsule attached to a thread dissolves in the stomach and releases a sponge that collects cells as it is pulled out. Guts UK says it is available in some areas of the UK for people with persistent heartburn and reflux, and positive results lead to an endoscopy.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-11, next review 2027-10-11.